| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/09/1995 | WO1995003825A1 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| 02/09/1995 | WO1995003824A1 Treatment of h. pylori associated gastroduodenal disease |
| 02/09/1995 | WO1995003814A1 Cellular vaccine and methods of use for the treatment of solid tumor malignancies |
| 02/09/1995 | WO1995003813A1 Novel eimeria antibodies and antigens and methods of using the same |
| 02/09/1995 | WO1995003777A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 02/09/1995 | WO1995003694A1 Method for making universal donor cells |
| 02/09/1995 | CA2168426A1 Recombinant vector containing a lipoprotein gene sequence expressing nucleotide sequences |
| 02/09/1995 | CA2168349A1 Intracellular immunization |
| 02/09/1995 | CA2168245A1 Polynucleotide decoys that inhibit mhc-ii expression and uses thereof |
| 02/09/1995 | CA2168230A1 Human antibodies against varicella-zoster virus |
| 02/09/1995 | CA2167938A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
| 02/09/1995 | CA2167835A1 Monoclonal iga antibody against respiratory syncytial virus |
| 02/09/1995 | CA2167730A1 Synthetic multiple tandem repeat mucin and mucin-like peptides and uses thereof |
| 02/09/1995 | CA2167712A1 Process for preparing stabilized immunoglobulins |
| 02/09/1995 | CA2167533A1 Novel eimeria antibodies and antigens and methods of using the same |
| 02/09/1995 | CA2167496A1 Immunoassay for the detection of collagen or collagen fragments |
| 02/08/1995 | EP0637631A2 Highly efficient expression of a polypeptide containing a modified preS1 region of the major hepatitis B virus antigen |
| 02/08/1995 | EP0637593A1 Bispecific trigger molecules recognizing lymphocyte antigen CD2 and tumor antigens |
| 02/08/1995 | EP0637337A1 Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine |
| 02/08/1995 | EP0637336A1 Mn gene and protein |
| 02/08/1995 | EP0637335A1 Recombinant mutants for inducing specific immune responses |
| 02/08/1995 | EP0637334A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization |
| 02/08/1995 | EP0637333A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 02/08/1995 | EP0637253A1 Carboxamide modified polyamine chelators and radioactive complexes and conjugates |
| 02/08/1995 | EP0637250A1 Inactivated mycoplasma hyopneumoniae and uses therefor |
| 02/08/1995 | EP0637249A1 Suppression of proliferative response and induction of tolerance with polymorphic class ii mhc allopeptides |
| 02/08/1995 | EP0637237A1 Calcium receptor-active molecules |
| 02/08/1995 | EP0637201A1 Method for inducing tumor immunity |
| 02/08/1995 | CN1098315A Hepatitis B gene vaccine transfer factor and immune RNA and its technology |
| 02/08/1995 | CN1098289A Immunle ribonucleic acid and transfer factor for resisting polytypic hepatitis and technology thereof |
| 02/07/1995 | US5387744 Avirulent microbes and uses therefor: Salmonella typhi |
| 02/07/1995 | US5387676 MN gene and protein |
| 02/07/1995 | US5387578 Releasing drugs from bioactive agents in order to improve the therapeutic efficacy and reduce their toxic effects |
| 02/07/1995 | US5387511 Extraction procedure for Chlamydia and Neisseria antigens |
| 02/07/1995 | US5387504 Monospecific antibodies and assay system for detecting stromelysin cleavage products |
| 02/07/1995 | US5387414 Comprising peptide immunogen with novel epitopes |
| 02/07/1995 | CA2103693A1 Animal model of the human immune system |
| 02/02/1995 | WO1995003418A2 Recombinant bcg vaccines |
| 02/02/1995 | WO1995003417A2 Homologously recombinant slow growing mycobacteria and uses therefor |
| 02/02/1995 | WO1995003415A2 Epstein-barr virus dna sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests |
| 02/02/1995 | WO1995003414A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 02/02/1995 | WO1995003413A1 High level expression, purification and refolding of the neisseria meningitidis outer membrane group b porin proteins |
| 02/02/1995 | WO1995003408A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | WO1995003335A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | WO1995003328A2 Melanoma-inhibiting protein |
| 02/02/1995 | WO1995003326A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | WO1995003324A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003323A1 Oncoprotein protein kinase |
| 02/02/1995 | WO1995003296A1 Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives |
| 02/02/1995 | WO1995003070A1 Recombinant swinepox virus |
| 02/02/1995 | WO1995003069A1 Method for expression and purification of p2 protein from haemophilus influenzae type b |
| 02/02/1995 | WO1994029446A3 Intracellular binding proteins and use thereof |
| 02/02/1995 | WO1994029350A3 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 02/02/1995 | WO1994026925A3 Processes for producing an enzyme |
| 02/02/1995 | CA2168096A1 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 02/02/1995 | CA2167808A1 Method for expression and purification of p2 protein from haemophilus influenzae type b |
| 02/02/1995 | CA2167677A1 Method for the high level expression, purification and refolding of the outer membrane group b porin proteins from neisseria meningitidis |
| 02/02/1995 | CA2167303A1 Regulation of transcription factor, nf-il6/lap |
| 02/02/1995 | CA2167302A1 Oncoprotein protein kinase |
| 02/02/1995 | CA2167091A1 B7-2: ctl a4/cd 28 counter receptor |
| 02/02/1995 | CA2166782A1 Haptens, tracers, immunogens and antibodies for carbazole and dibenzofuran derivatives |
| 02/01/1995 | EP0636182A1 Antibodies for treatment and prevention of respiratory syncytial virus infection |
| 02/01/1995 | EP0636180A1 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA) |
| 02/01/1995 | EP0636177A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN $g(b) SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E |
| 02/01/1995 | EP0636176A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily |
| 02/01/1995 | EP0636173A1 Treatment of hiv-associated immune thrombocytopenic purpura |
| 02/01/1995 | EP0636172A1 Genetically engineered attenuated viruses |
| 02/01/1995 | EP0636145A1 Synthetic polypeptides derived from the hiv envelope glycoprotein |
| 02/01/1995 | EP0636030A1 pasteurella haemolytica type a-1 bacterin-toxoid vaccine |
| 02/01/1995 | EP0636029A1 Antibodies specific for carcinoma-associated antigens |
| 02/01/1995 | EP0535150B1 Human macrophage inflammatory protein 2-beta |
| 02/01/1995 | EP0500736B1 Recombinant vaccine for porcine pleuropneumonia |
| 02/01/1995 | CN1098140A Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 01/31/1995 | US5385740 Biologically active material characterized by catabolic activity generally associated with cachexia-inducing tumors, preparations, production and uses thereof |
| 01/31/1995 | CA2129156A1 High level expression of polypeptide that contains modified pres1 region of hepatitis b virus large antigen |
| 01/31/1995 | CA1334177C Production of chimeric antibodies by homologous recombination |
| 01/31/1995 | CA1334176C Monoclonal antibody recognizing gamma atrial natriuretic polypeptide |
| 01/31/1995 | CA1334165C Affinity associated vaccine |
| 01/27/1995 | CA2128742A1 Oil-based and water-based adjuvant mixture |
| 01/27/1995 | CA2128547A1 Method for the separation of bacterial lipopolysaccharides from protein-containing solutions |
| 01/26/1995 | WO1995002686A1 Redirection of cellular immunity by receptor chimeras |
| 01/26/1995 | WO1995002628A1 Polyphosphazenes useful as immunoadjuvants |
| 01/26/1995 | WO1995002421A1 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
| 01/26/1995 | WO1995002417A1 Methods for the cultivation of infectious laryngotracheitis virus and egg drop syndrome virus |
| 01/26/1995 | WO1995002416A1 Hydrogel microencapsulated vaccines |
| 01/26/1995 | WO1995002415A1 Phosphazene polyelectrolytes as immunoadjuvants |
| 01/26/1995 | WO1995002413A1 Suppression of inhibitors |
| 01/26/1995 | WO1995002412A1 Antiallergic agent |
| 01/26/1995 | CA2167081A1 Hydrogel microencapsulated vaccines |
| 01/26/1995 | CA2166875A1 Transferrin receptor specific ligand-neuro-pharmaceutical agent fusion proteins |
| 01/25/1995 | EP0635575A1 Monoclonal antibodies against epitopes found in free but not in alpha-1-antichmotrypsin complexed prostate specific antigen |
| 01/25/1995 | EP0635271A1 Therapeutic kits against proteinacious mediators, method of preparation and pharmaceutical compositions containing them |
| 01/25/1995 | EP0635132A1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
| 01/25/1995 | EP0635062A1 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF mRNA |
| 01/25/1995 | EP0635060A1 Myogenic vector systems |
| 01/25/1995 | EP0635059A1 Polysaccharide binding fusion proteins and conjugates |
| 01/25/1995 | EP0635058A1 Protease vaccine against heartworm |
| 01/25/1995 | EP0635056A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor |
| 01/25/1995 | EP0635055A1 $i(HAEMOPHILUS SOMNUS) IMMUNOGENIC PROTEINS |
| 01/25/1995 | EP0635054A1 Mammalian melanocyte stimulating hormone receptors and uses |